Centre rejects reports of dissent by experts on Covishield doses gap

The 22nd meeting of COVID-19 Working Group of NTAGI was held on May 10. There, a proposal for a change in dose interval for Covishield, used under the National Vaccination Policy, was considered. Based on the real-life evidences, particularly from the United Kingdom, the COVID-19 Working Group agreed to increase the interval between two doses of Covishield Vaccine to 12 to 16 weeks, the Health Ministry said in a statement.